Purpose-led. Expert-Driven.

We exist to guide science when it’s most fragile and full of promise. At Linden Lake Labs, we work at the critical first stages—where ideas become assets, and potential becomes progress. This is where impact begins, and where we do our best work.

Our Mission

Transform Breakthrough Science into Scalable, High-Impact Companies

Our Vision

To build a diversified, capital-efficient life sciences platform that transforms breakthrough science into scalable businesses, accelerating novel therapies and technologies to patients worldwide.

Advancing Science with Structure and Vision

Advancing Science with Structure and Vision

Breakthroughs don’t start with headlines. They start with a spark—an insight at the bench, a new angle on an old challenge, a hypothesis that just might change everything.

Linden Lake Labs is a life sciences platform built to translate early-stage innovation into scalable companies. We partner with founders and scientists to develop preclinical therapeutics in oncology, neurological disease, and rare conditions.

With deep experience in IP, finance, and drug development, we bring structure to the earliest moments of growth. Our model combines strategic investment, centralized resources, and active operational guidance to help new ventures move forward with clarity and conviction.

shutterstock_719542471.jpg
ced530a069a1e34393c15306ec02dea668500dfb-scaled-1-1.jpg
bbb7bccc61060592066698e9cb0fb0757a9d9e9b-scaled-1.jpg
pexels-ivan-samkov-9629665-scaled-1.jpg

Company Building & Investment

Early Focus, High Impact

Operational Precision

Proven Leadership

We build new companies around strong science and selectively invest in aligned startups. Each venture receives customized support—capital, infrastructure, and operational leadership tailored to its stage and needs.

We concentrate on seed and pre-Series A science. At this stage, value creation is most dynamic, and the right decisions can change everything. This is where we drive the greatest impact.

Our hub-and-spoke model centralizes key services like legal, finance, and IP management. This reduces friction, increases capital efficiency, and ensures consistency across our portfolio.

Our team includes founders with multiple biotech exits, and advisors with decades of experience across therapeutic development, intellectual property, and corporate strategy.

  • Company Building & Investment
  • Early Focus, High Impact
  • Operational Precision
  • Proven Leadership
shutterstock_719542471.jpg
ced530a069a1e34393c15306ec02dea668500dfb-scaled-1-1.jpg
bbb7bccc61060592066698e9cb0fb0757a9d9e9b-scaled-1.jpg
pexels-ivan-samkov-9629665-scaled-1.jpg

Company Building & Investment

Early Focus, High Impact

Operational Precision

Proven Leadership

We build new companies around strong science and selectively invest in aligned startups. Each venture receives customized support—capital, infrastructure, and operational leadership tailored to its stage and needs.

We concentrate on seed and pre-Series A science. At this stage, value creation is most dynamic, and the right decisions can change everything. This is where we drive the greatest impact.

Our hub-and-spoke model centralizes key services like legal, finance, and IP management. This reduces friction, increases capital efficiency, and ensures consistency across our portfolio.

Our team includes founders with multiple biotech exits, and advisors with decades of experience across therapeutic development, intellectual property, and corporate strategy.

  • Company Building & Investment
  • Early Focus, High Impact
  • Operational Precision
  • Proven Leadership

Our Approach

We support early-stage therapeutic ventures grounded in strong IP and positioned for long-term value.

Across the board, Linden Lake Labs plays an active role in shaping company direction—from IP development and regulatory strategy to investor outreach and exit planning.

Companies We Build

Built from the ground up by Linden Lake Labs, these companies are supported with capital, infrastructure, and operational leadership from day one.

Companies We Build

External ventures at the seed or pre-Series A stage that align with our scientific and strategic priorities. We invest capital and provide support where it matters most.

Leadership

Abhishake Chhibber, MBA

Co-Founder, Chief Business Officer

Abhishake Chhibber has led strategy and corporate development roles across the biopharma industry, including leadership positions at BioNTech SE and AstraZeneca. His work in portfolio management, fundraising, and venture formation guides how Linden Lake Labs identifies and grows high-potential therapeutics from day one.

Thomas Axel Haag, Ph.D., J.D.

Co-Founder, Chief Executive Officer

Dr. Haag brings over 25 years of experience in biotechnology, intellectual property, and executive leadership. He has served as CEO of AexeRNA Therapeutics (acquired by BioNTech) and PhosImmune (acquired by Agenus), and previously worked as General Counsel for Arrowhead Research Corporation. His dual expertise in science and law shapes Linden Lake Labs’ operator-first, IP-strong approach to biotech company building.

Join Our Team

Whether you’re building a venture, launching a scientific breakthrough, or looking to invest in meaningful biotech innovation—there’s a place for you here.

Our work is bold, focused, and always moving forward. If that speaks to you, we invite you to explore how you might be part of it.

Invest in what
comes next

If you’re looking to fund meaningful science, partner with early ventures, or understand how we create value—Linden Lake Labs is built for the earliest and most critical stages of biotech innovation.

Learn how we combine capital, strategy, and operational discipline to move science forward from day one.

We are here to connect

If you’re a founder, scientist, investor, or simply curious about our work, we’d like to connect.
Great ideas deserve great partners. Let’s talk about what we can build together.